Clinical trials
Completed Lymphoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
118 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 4 |
| 2002 | 6 |
| 2003 | 7 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 9 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 118 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 18 |
| NCIC Clinical Trials Group | 11 |
| Alliance for Clinical Trials in Oncology | 6 |
| Seagen Inc. | 6 |
| University Health Network, Toronto | 6 |
| Bristol-Myers Squibb | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| National Cancer Institute (NCI) | 3 |
| Symphogen A/S | 3 |
| Bayer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 118 |
| Lymphoma, Non-Hodgkin | 28 |
| Lymphoma, Large B-Cell, Diffuse | 26 |
| Hodgkin Disease | 24 |
| Burkitt Lymphoma | 21 |
| Lymphoma, Follicular | 17 |
| Recurrence | 16 |
| Leukemia | 15 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 15 |
| Lymphoma, Mantle-Cell | 14 |
Trials
Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.
18 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.